Observing in real time the evolution of artemisinin resistance in Plasmodium falciparum

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Artemisinin resistance; Genomic analysis; Malaria; Molecular markers; Plasmodium falciparum

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; DRUG EFFICACY; DRUG POTENCY; DRUG USE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; MOLECULAR EVOLUTION; NONHUMAN; NOTE; PARASITE CLEARANCE; PARASITE IDENTIFICATION; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIA; EVOLUTION; MALARIA, FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; BIOLOGICAL EVOLUTION; GENOTYPE; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84928154142     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0316-5     Document Type: Note

References (43)

1. Davies SC, Grant J, Catchpole M. The drugs don't work - a global threat. Penguin Books, Ltd.; 2013.
2. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619-20.
3. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
4. World Health Organization. Global plan for containment of artemisinin resistance. http://www.who.int/malaria/publications/atoz/9789241500838/en/index.html . Accessed 22 Feb 2015.
5. Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015. doi:10.1038/ng.3189.
6. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011;6:e19283.
7. Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A, et al. Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One. 2012;7:e52236.
8. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851-8.
9. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960-6.
10. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A. 2013;110:240-5.
11. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One. 2013;8:e57689.
12. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, et al. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg. 2012;87:23-8.
13. Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.
14. Witkowski B, Lelievre J, Lopez Barragan MJ, Laurent V, Su X-z, Berry A, et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother. 2010;54:1872-7.
15. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914-23.
16. Amaratunga C, Witkowski B, Khim N, Menard D, Fairhurst RM. Artemisinin resistance in Plasmodium falciparum. Lancet Infect Dis. 2014;14:449-50.
17. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
18. Sibley CH, Price RN. Monitoring antimalarial drug resistance: applying lessons learned from the past in a fast-moving present. Int J Parasitol Drugs Drug Resist. 2012;2:126-33.
19. Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis. 2010;201:1326-30.
20. Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 2013;45:648-55.
21. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, et al. A major genome region underlying artemisinin resistance in malaria. Science. 2012;336:79-82.
22. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5.
23. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2015;211:670-9.
24. Thriemer K, Hong NV, Rosanas-Urgell A, Phuc BQ, do Ha M, Pockele E, et al. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob Agents Chemother. 2014;58:7049-55.
25. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Lin K, et al.Westward expansion of artemisinin resistant P. falciparum across Myanmar. Lancet Infect Dis. 2015. doi: 10.1016/S1473-3099(15)70032-0.
26. Preston MD, Assefa SA, Ocholla H, Sutherland CJ, Borrmann S, Nzila A, et al. PlasmoView: a Web-based resource to visualise global Plasmodium falciparum genomic variation. J Infect Dis. 2014;209:1808-15.
27. Plasmodium falciparum genetic variations (SNPs) & allele frequencies. http://explorercat.sanger.ac.uk/ExplorerCat-pgv/pub/executePlugin.action?pluginName=PopGen+Explorer&selectedCatalogId=1 . Accessed 22 Feb 2015.
28. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, et al. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014;9:e105690.
29. Mishra N, Prajapati SK, Kaitholia K, Bharti RS, Srivastava B, Phookan S, et al. Surveillance for artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker. Antimicrob Agents Chemother. 2015. doi: 10.1128/AAC.04632-14.
30. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2014.doi: 10.1093/infdis/jiu608.
31. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680-8.
32. Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, et al. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Malar J. 2014;13:472.
33. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol. 2014;32:819-21.
34. Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428-31.
35. Klonis N, Creek DJ, Tilley L. Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins. Curr Opin Microbiol. 2013;16:722-7.
36. Klonis N, Xie SC, McCaw JM, Crespo-Ortiz MP, Zaloumis SG, Simpson JA, et al. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc Natl Acad Sci U S A. 2013;110:5157-62.
37. Mok S, Imwong M, Mackinnon MJ, Sim J, Ramadoss R, Yi P, et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics. 2011;12:391.
38. Cortese JF, Caraballo A, Contreras CE, Plowe CV. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis. 2002;186:999-1006.
39. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.
40. Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006;5:34.
41. Plowe CV. The evolution of drug-resistant malaria. Trans R Soc Trop Med Hyg. 2009;103:S11-4.
42. Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau-Puijalon O, et al. Molecular surveillance for artemisinin resistance in Africa. Lancet Infect Dis. 2014;14:668-70.
43. Menard D, Ariey F. Towards real-time monitoring of artemisinin resistance. J Infect Dis. 2015: doi:10.1016/s1473-3099(15)70046-0.